Clinical trial
XIENCE V: SPIRIT WOMEN
NCT00496938 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00496938 |
|---|---|
| Title | XIENCE V: SPIRIT WOMEN |
| Official title | A Clinical Evaluation of the XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Women With de Novo Coronary Artery Lesions |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Stenosis, Coronary Arteriosclerosis, Coronary Artery Disease, Coronary Artery Restenosis, Total Coronary Occlusion, Stent Thrombosis, Vascular Disease, Myocardial Ischemia |
| Intervention type | Device |
| Interventions | XIENCE V®/ XIENCE PRIME™ |
| Enrollment | 1,600 |
| Start date | Jul 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Jul 1, 2011 |
| First posted | Jul 6, 2007 |
| Last update posted | May 13, 2015 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, China, Denmark, France, Germany, Greece, Hungary, India and 14 more |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: